Wednesday, December 12, 2012
Oramed Pharmaceuticals Inc., of Jerusalem, completed a financing, issuing 13.7 million units at 37 cents apiece for net proceeds of $5 million. Each unit included one share of stock.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.